78
Participants
Start Date
January 24, 2021
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Anti-Diabetics
The anti-diabetic treatments include insulin glargine, insulin aspart, GLP-1 receptor agonist, DPP-4 inhibitor, SGLT-2 inhibitor, metformin, sulfonylureas and/or gliclazide. Therapeutic dose of each drug follows recommendation by the treating doctor.
Nanjing First Hospital, Nanjing
The First Affiliated Hospital with Nanjing Medical University
OTHER
University of Adelaide
OTHER